-
1
-
-
0000009816
-
Serum uric acid in relation to age and physique in health and coronary heart disease
-
Gertler M, Garn S, Levine S. Serum uric acid in relation to age and physique in health and coronary heart disease. Ann Intern Med 1951;34:1421-31
-
(1951)
Ann Intern Med
, vol.34
, pp. 1421-1431
-
-
Gertler, M.1
Garn, S.2
Levine, S.3
-
2
-
-
85047692424
-
Serum uric acid: Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia
-
Klein R, Klein B, Cornoni J, et al. Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 1973;132:401-10
-
(1973)
Arch Intern Med
, vol.132
, pp. 401-410
-
-
Klein, R.1
Klein, B.2
Cornoni, J.3
-
3
-
-
1542510891
-
Uric acid: Role in cardiovascular disease and effects of losartan
-
DOI 10.1185/030079904125002982
-
Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin 2004;20:369-79 (Pubitemid 38339177)
-
(2004)
Current Medical Research and Opinion
, vol.20
, Issue.3
, pp. 369-379
-
-
Alderman, M.1
Aiyer, K.J.V.2
-
4
-
-
0344199826
-
Is raised serum uric acid a cause of cardiovascular disease or death?
-
DOI 10.1016/S0140-6736(99)00260-3
-
Dobson A. Is raised serum uric acid a cause of cardiovascular disease or death? Lancet 1999;354:1578 (Pubitemid 29515947)
-
(1999)
Lancet
, vol.354
, Issue.9190
, pp. 1578
-
-
Dobson, A.1
-
5
-
-
11244253742
-
Resurrection of uric acid as a causal risk factor in essential hypertension
-
DOI 10.1161/01.HYP.0000150785.39055.e8
-
Johnson RJ, Feig DI, Herrera-Acosta J, et al. Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 2005;45:18-20 (Pubitemid 40066407)
-
(2005)
Hypertension
, vol.45
, Issue.1
, pp. 18-20
-
-
Johnson, R.J.1
Feig, D.I.2
Herrera-Acosta, J.3
Kang, D.-H.4
-
6
-
-
0036558561
-
Urate levels as a predictor of cardiac deaths: Causal relation or mere association?
-
DOI 10.1053/euhj.2001.3126
-
Yusuf S, Bosch J. Urate levels as a predictor of cardiac deaths: causal relation or mere association? Eur Heart J 2002;23:760-1 (Pubitemid 35238485)
-
(2002)
European Heart Journal
, vol.23
, Issue.10
, pp. 760-761
-
-
Yusuf, S.1
Bosch, J.2
-
7
-
-
0033670512
-
Relation between serum uric acid and risk of cardiovascular disease in essential hypertension
-
Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000;36:1072-8
-
(2000)
The PIUMA Study. Hypertension
, vol.36
, pp. 1072-1078
-
-
Verdecchia, P.1
Schillaci, G.2
Reboldi, G.3
-
9
-
-
84858698191
-
Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey 1999-2006
-
Loeffler LF, Navas-Acien A, Brady TM, et al. Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006. Hypertension 2012;59:811-17
-
(2012)
Hypertension
, vol.59
, pp. 811-817
-
-
Loeffler, L.F.1
Navas-Acien, A.2
Brady, T.M.3
-
10
-
-
34447318846
-
Association between serum uric acid and prehypertension among US adults
-
DOI 10.1097/HJH.0b013e32813aeb6c, PII 0000487220070800000010
-
Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens 2007;25:1583-9 (Pubitemid 47056563)
-
(2007)
Journal of Hypertension
, vol.25
, Issue.8
, pp. 1583-1589
-
-
Syamala, S.1
Li, J.2
Shankar, A.3
-
11
-
-
10744221128
-
The impact of serum uric acid on cardiovascular outcomes in the LIFE study
-
DOI 10.1111/j.1523-1755.2004.00484.x
-
Hoieggen A, Alderman MH, Kjeldsen SE, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004;65:1041-9 (Pubitemid 38251080)
-
(2004)
Kidney International
, vol.65
, Issue.3
, pp. 1041-1049
-
-
Hoieggen, A.1
Alderman, M.H.2
Kjeldsen, S.E.3
Julius, S.4
Devereux, R.B.5
De Faire, U.6
Fyhrquist, F.7
Ibsen, H.8
Kristianson, K.9
Lederballe-Pedersen, O.10
Lindholm, L.H.11
Nieminen, M.S.12
Omvik, P.13
Oparil, S.14
Wedel, H.15
Chen, C.16
Dahlof, B.17
-
12
-
-
0041402693
-
Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke
-
Weir CJ, Muir SW, Walters MR, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003;34:1951-7
-
(2003)
Stroke
, vol.34
, pp. 1951-1957
-
-
Weir, C.J.1
Muir, S.W.2
Walters, M.R.3
-
13
-
-
33746228618
-
Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes
-
DOI 10.1097/01.hjr.0000192745.26973.00, PII 0014983120060400000008
-
Gerber Y, Tanne D, Medalie JH, et al. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil 2006;13:193-8 (Pubitemid 44097723)
-
(2006)
European Journal of Cardiovascular Prevention and Rehabilitation
, vol.13
, Issue.2
, pp. 193-198
-
-
Gerber, Y.1
Tanne, D.2
Medalie, J.H.3
Goldbourt, U.4
-
14
-
-
84872094694
-
An association between uric acid levels and renal arteriolopathy in chronic kidney disease: A biopsy-based study
-
Kohagura K, Kochi M, Miyagi T, et al. An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res 2013;36:43-9
-
(2013)
Hypertens Res
, vol.36
, pp. 43-49
-
-
Kohagura, K.1
Kochi, M.2
Miyagi, T.3
-
15
-
-
79251557504
-
Uric acid as a predictor of all-cause mortality in heart failure: A meta-analysis
-
Tamariz L, Harzand A, Palacio A, et al. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congestive Heart Failure 2011;17:25-30
-
(2011)
Congestive Heart Failure
, vol.17
, pp. 25-30
-
-
Tamariz, L.1
Harzand, A.2
Palacio, A.3
-
16
-
-
0038119701
-
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
-
DOI 10.1161/01.HYP.0000069700.62727.C5
-
Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-90 (Pubitemid 36706063)
-
(2003)
Hypertension
, vol.41
, Issue.6
, pp. 1183-1190
-
-
Johnson, R.J.1
Kang, D.-H.2
Feig, D.3
Kivlighn, S.4
Kanellis, J.5
Watanabe, S.6
Tuttle, K.R.7
Rodriguez-Iturbe, B.8
Herrera-Acosta, J.9
Mazzali, M.10
-
17
-
-
18244367869
-
Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: Prospective study and meta-analysis
-
Wheeler JG, Juzwishin KD, Eiriksdottir G, et al. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med 2005;2:e76
-
(2005)
PLoS Med
, vol.2
-
-
Wheeler, J.G.1
Juzwishin, K.D.2
Eiriksdottir, G.3
-
18
-
-
84859960120
-
Novara Atherosclerosis Study Group (NAS). Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study
-
De Luca G, Secco GG, Santagostino M, et al; Novara Atherosclerosis Study Group (NAS). Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis 2012;22:426-33
-
(2012)
Nutr Metab Cardiovasc Dis
, vol.22
, pp. 426-433
-
-
De Luca, G.1
Secco, G.G.2
Santagostino, M.3
-
19
-
-
27944465651
-
Serum uric acid and risk of coronary heart disease
-
DOI 10.2174/138161205774913200
-
Wannamethee SG. Serum uric acid and risk of coronary heart disease. Curr Pharm Des 2005;11:4125-32 (Pubitemid 41672461)
-
(2005)
Current Pharmaceutical Design
, vol.11
, Issue.32
, pp. 4125-4132
-
-
Wannamethee, S.G.1
-
20
-
-
39549086157
-
Uric acid administration in patients with acute stroke: A novel approach to neuroprotection
-
DOI 10.1586/14737175.8.2.259
-
Amaro S, Planas AM, Chamorro A. Uric acid administration in patients with acute stroke: a novel approach to neuroprotection. Expert Rev Neurother 2008;8:259-70 (Pubitemid 351281113)
-
(2008)
Expert Review of Neurotherapeutics
, vol.8
, Issue.2
, pp. 259-270
-
-
Amaro, S.1
Planas, A.M.2
Chamorro, A.3
-
21
-
-
23244462442
-
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
-
DOI 10.1016/j.amjmed.2005.03.043, PII S0002934305003426
-
Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005;118:816-26 (Pubitemid 41097455)
-
(2005)
American Journal of Medicine
, vol.118
, Issue.8
, pp. 816-826
-
-
Baker, J.F.1
Krishnan, E.2
Chen, L.3
Schumacher, H.R.4
-
22
-
-
39749183442
-
Serum uric acid and risk of cardiovascular mortality: A prospective long-term study of 83 683 Austrian men
-
DOI 10.1373/clinchem.2007.094425
-
Strasak A, Ruttmann E, Brant L, et al. Serum uric acid and risk of cardiovascular mortality: a prospective longterm study of 83,683 Austrian men. Clin Chem 2008;54:273-84 (Pubitemid 351302628)
-
(2008)
Clinical Chemistry
, vol.54
, Issue.2
, pp. 273-284
-
-
Strasak, A.1
Ruttmann, E.2
Brant, L.3
Kelleher, C.4
Klenk, J.5
Concin, H.6
Diem, G.7
Pfeiffer, K.8
Ulmer, H.9
Gmeiner, P.10
Metzler, W.11
Stimpfl, E.12
Rapp, K.13
Weiland, S.K.14
Oberaigner, W.15
-
23
-
-
44349151051
-
Long-term cardiovascular mortality among middle-aged men with gout
-
DOI 10.1001/archinte.168.10.1104
-
Krishnan E, Svendsen K, Neaton JD, et al. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008;168: 1104-10 (Pubitemid 351749228)
-
(2008)
Archives of Internal Medicine
, vol.168
, Issue.10
, pp. 1104-1110
-
-
Krishnan, E.1
Svendsen, K.2
Neaton, J.D.3
Grandits, G.4
Kuller, L.H.5
-
24
-
-
80054069941
-
Xanthine oxidase and uric acid in cardiovascular disease: Clinical impact and therapeutic options
-
Doehner W, Landmesser U. Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Semin Nephrol 2011;31: 433-40
-
(2011)
Semin Nephrol
, vol.31
, pp. 433-440
-
-
Doehner, W.1
Landmesser, U.2
-
25
-
-
3242785541
-
Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study
-
DOI 10.1001/archinte.164.14.1546
-
Niskanen LK, Laaksonen DL, Nyyssö nen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men. Arch Intern Med 2004;164:1546-51 (Pubitemid 38970476)
-
(2004)
Archives of Internal Medicine
, vol.164
, Issue.14
, pp. 1546-1551
-
-
Niskanen, L.K.1
Laaksonen, D.E.2
Nyyssonen, K.3
Alfthan, G.4
Lakka, H.-M.5
Lakka, T.A.6
Salonen, J.T.7
-
27
-
-
0023839830
-
Gout and coronary heart disease: The Framingham Study
-
DOI 10.1016/0895-4356(88)90127-8
-
Abbott RD, Brand FN, Kannel WB, et al. Gout and coronary heart disease: the Framingham study. J Clin Epidemiol 1988;41:237-42 (Pubitemid 18069583)
-
(1988)
Journal of Clinical Epidemiology
, vol.41
, Issue.3
, pp. 237-242
-
-
Abbott, R.D.1
Brand, F.N.2
Kannel, W.B.3
Castelli, W.P.4
-
28
-
-
34548142983
-
Independent impact of gout on mortality and risk for coronary heart disease
-
DOI 10.1161/CIRCULATIONAHA.107.703389, PII 0000301720070821000006
-
Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007;116:894-900 (Pubitemid 47300913)
-
(2007)
Circulation
, vol.116
, Issue.8
, pp. 894-900
-
-
Choi, H.K.1
Curhan, G.2
-
29
-
-
77953479639
-
Gout: An independent risk factor for all-cause and cardiovascular mortality
-
Kuo CF, See LC, Luo SF, et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology 2010;49:141-6
-
(2010)
Rheumatology
, vol.49
, pp. 141-146
-
-
Kuo, C.F.1
See, L.C.2
Luo, S.F.3
-
30
-
-
62549112964
-
Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A Chinese cohort study
-
Chen JH, Chuang SY, Chen HJ, et al. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Care Res 2009;61:225-32
-
(2009)
Arthritis Care Res
, vol.61
, pp. 225-232
-
-
Chen, J.H.1
Chuang, S.Y.2
Chen, H.J.3
-
31
-
-
39749157632
-
Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A Preventive Cardiology Information System (PreCIS) database cohort study
-
DOI 10.1002/art.23121
-
Ioachimescu AG, Brennan DM, Hoar BM, et al. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008;58:623-30 (Pubitemid 351294901)
-
(2008)
Arthritis and Rheumatism
, vol.58
, Issue.2
, pp. 623-630
-
-
Ioachimescu, A.G.1
Brennan, D.M.2
Hoar, B.M.3
Hazen, S.L.4
Hoogwerf, B.J.5
-
32
-
-
0034630917
-
Serum uric acid and cardiovascular mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
-
Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-10 (Pubitemid 30257539)
-
(2000)
Journal of the American Medical Association
, vol.283
, Issue.18
, pp. 2404-2410
-
-
Fang, J.1
Alderman, M.H.2
-
33
-
-
0036147865
-
Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease
-
DOI 10.1016/S0002-9149(01)02155-5, PII S0002914901021555
-
Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002;89:12-17 (Pubitemid 34066579)
-
(2002)
American Journal of Cardiology
, vol.89
, Issue.1
, pp. 12-17
-
-
Bickel, C.1
Rupprecht, H.J.2
Blankenberg, S.3
Rippin, G.4
Hafner, G.5
Daunhauer, A.6
Hofmann, K.-P.7
Meyer, J.8
-
34
-
-
0032791505
-
Serum uric acid and cardiovascular events in successfully treated hypertensive patients
-
Alderman MH, Cohen H, Madhavan S, et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999;34:144-50 (Pubitemid 29325733)
-
(1999)
Hypertension
, vol.34
, Issue.1
, pp. 144-150
-
-
Alderman, M.H.1
Cohen, H.2
Madhavan, S.3
Kivlighn, S.4
-
35
-
-
0033800597
-
Antioxidant profile and early outcome in Stroke patients
-
Cherubini A, Polidori MC, Bregnocchi M, et al. Antioxidant profile and early outcome in Stroke patients. Stroke 2000;31:2295-300
-
(2000)
Stroke
, vol.31
, pp. 2295-2300
-
-
Cherubini, A.1
Polidori, M.C.2
Bregnocchi, M.3
-
36
-
-
79551674574
-
Prevalence of contraindications and prescription of pharmacologic therapies for gout
-
Keenan RT, O'Brien WR, Lee KH, et al. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med 2011; 124:155-63
-
(2011)
Am J Med
, vol.124
, pp. 155-163
-
-
Keenan, R.T.1
O'Brien, W.R.2
Lee, K.H.3
-
37
-
-
84862643926
-
Elevated uric acid, the metabolic syndrome and cardiovascular disease: Cause, consequence, or just a not so innocent bystander?
-
Santos RD. Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander? Endocrine 2012;41:350-2
-
(2012)
Endocrine
, vol.41
, pp. 350-352
-
-
Santos, R.D.1
-
38
-
-
79959424654
-
From risk factor assessment to cardiovascular disease risk and mortality modification: The first 40 years of the Brisighella Heart Study
-
Cicero AFG, Dormi A, D'Addato S, Borghi C. From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study. Clinical Lipidology 2011;6:269-76
-
(2011)
Clinical Lipidology
, vol.6
, pp. 269-276
-
-
Cicero, A.F.G.1
Dormi, A.2
D'Addato, S.3
Borghi, C.4
-
39
-
-
84862648876
-
Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome
-
Gonç alves JP, Oliveira A, Severo M, et al. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 2012;41:450-7
-
(2012)
Endocrine
, vol.41
, pp. 450-457
-
-
Gonçalves, J.P.1
Oliveira, A.2
Severo, M.3
-
40
-
-
33645560926
-
A causal role for uric acid in fructose-induced metabolic syndrome
-
DOI 10.1152/ajprenal.00140.2005
-
Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructoseinduced metabolic syndrome. Am J Physiol Renal Physiol 2006;290:F625-31 (Pubitemid 43724964)
-
(2006)
American Journal of Physiology - Renal Physiology
, vol.290
, Issue.3
-
-
Nakagawa, T.1
Hu, H.2
Zharikov, S.3
Tuttle, K.R.4
Short, R.A.5
Glushakova, O.6
Ouyang, X.7
Feig, D.I.8
Block, E.R.9
Herrera-Acosta, J.10
Patel, J.M.11
Johnson, R.J.12
-
41
-
-
0141962657
-
Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation
-
DOI 10.1161/01.HYP.0000091371.53502.D3
-
Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003;42:474-80 (Pubitemid 37237341)
-
(2003)
Hypertension
, vol.42
, Issue.4
, pp. 474-480
-
-
Masuo, K.1
Kawaguchi, H.2
Mikami, H.3
Ogihara, T.4
Tuck, M.L.5
-
42
-
-
34548739656
-
Relationship between hyperuricemia and body fat distribution
-
DOI 10.2169/internalmedicine.46.0045
-
Hikita M, Ohno I, Mori Y, et al. Relationship between hyperuricemia and body fat distribution. Intern Med 2007;46:1353-8 (Pubitemid 47455757)
-
(2007)
Internal Medicine
, vol.46
, Issue.17
, pp. 1353-1358
-
-
Hikita, M.1
Ohno, I.2
Mori, Y.3
Ichida, K.4
Yokose, T.5
Hosoya, T.6
-
43
-
-
0028939936
-
Sympathetic activation in obese normotensive subjects
-
Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995;25(4 Pt 1):560-3
-
(1995)
Hypertension
, vol.25
, Issue.4 PART 1
, pp. 560-563
-
-
Grassi, G.1
Seravalle, G.2
Cattaneo, B.M.3
-
44
-
-
84884704487
-
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study
-
May 25 [Epub ahead of print]
-
Bombelli M, Facchetti R, Fodri D et al. Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: data from the PAMELA study. Nutr Metab Cardiovasc Dis 2012 May 25 [Epub ahead of print]
-
(2012)
Nutr Metab Cardiovasc Dis
-
-
Bombelli, M.1
Facchetti, R.2
Fodri, D.3
-
45
-
-
0037024270
-
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: Results from 2 placebo-controlled studies
-
DOI 10.1161/01.CIR.0000017502.58595.ED
-
Doehner V, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebocontrolled studies. Circulation 2002;105:2619-24 (Pubitemid 34596038)
-
(2002)
Circulation
, vol.105
, Issue.22
, pp. 2619-2624
-
-
Doehner, W.1
Schoene, N.2
Rauchhaus, M.3
Leyva-Leon, F.4
Pavitt, D.V.5
Reaveley, D.A.6
Schuler, G.7
Coats, A.J.S.8
Anker, S.D.9
Hambrecht, R.10
-
46
-
-
0028047098
-
Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting
-
Coghlan JG, Flitter WD, Clutton SM, et al. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;107:248-56 (Pubitemid 24050525)
-
(1994)
Journal of Thoracic and Cardiovascular Surgery
, vol.107
, Issue.1
, pp. 248-256
-
-
Coghlan, J.G.1
Flitter, W.D.2
Clutton, S.M.3
Panda, R.4
Daly, R.5
Wright, G.6
Ilsley, C.D.7
Slater, T.F.8
-
47
-
-
84868202490
-
Uric acid reduction rectifies prehypertension in obese adolescents
-
Soletsky B, Feig DI. Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 2012;60:1148-56
-
(2012)
Hypertension
, vol.60
, pp. 1148-1156
-
-
Soletsky, B.1
Feig, D.I.2
-
48
-
-
67650074894
-
Allopurinol and mortality in hyperuricaemic patients
-
Luk AJ, Levin GP, Moore EE, et al. Allopurinol and mortality in hyperuricaemic patients. Rheumatology 2009;48:804-6
-
(2009)
Rheumatology
, vol.48
, pp. 804-806
-
-
Luk, A.J.1
Levin, G.P.2
Moore, E.E.3
-
49
-
-
79952608393
-
Impact of allopurinol use on urate concentration and cardiovascular outcome
-
Wei L, Mackenzie IS, Chen Y, et al. Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol 2011;71:600-7
-
(2011)
Br J Clin Pharmacol
, vol.71
, pp. 600-607
-
-
Wei, L.1
MacKenzie, I.S.2
Chen, Y.3
-
50
-
-
0142182438
-
Allopurinol as a Cardioprotectant During Coronary Artery Bypass Graft Surgery
-
DOI 10.1345/aph.1D023
-
Weimert NA, Tanke WF, Sims JJ. Allopurinol as a cardioprotective during coronary artery bypass graft surgery. Ann Pharmacother 2003;37:1708-11 (Pubitemid 37315114)
-
(2003)
Annals of Pharmacotherapy
, vol.37
, Issue.11
, pp. 1708-1711
-
-
Weimert, N.A.1
Tanke, W.F.2
Sims, J.J.3
-
51
-
-
0035856508
-
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy
-
Cappola TP, Kass DA, Nelson GS, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001;104:2407-11 (Pubitemid 33108372)
-
(2001)
Circulation
, vol.104
, Issue.20
, pp. 2407-2411
-
-
Cappola, T.P.1
Kass, D.A.2
Nelson, G.S.3
Berger, R.D.4
Rosas, G.O.5
Kobeissi, Z.A.6
Marban, E.7
Hare, J.M.8
-
52
-
-
80054113660
-
Effects of urate lowering therapy on cardiovascular mortality: A Taiwanese cohort study
-
Chen J-H, Pan W-H. Effects of urate lowering therapy on cardiovascular mortality: a Taiwanese cohort study. Arthritis Rheum 2010;62:S872-3
-
(2010)
Arthritis Rheum
, vol.62
-
-
Chen, J.-H.1
Pan, W.-H.2
-
53
-
-
77955442528
-
Gout, allopurinol use, and heart failure outcomes
-
Thanassoulis G, Brophy JM, Richard H, et al. Gout, allopurinol use, and heart failure outcomes. Arch Intern Med 2010;170:1358-64
-
(2010)
Arch Intern Med
, vol.170
, pp. 1358-1364
-
-
Thanassoulis, G.1
Brophy, J.M.2
Richard, H.3
-
54
-
-
0032402381
-
Uric acid in chronic heart failure: A marker of chronic inflammation
-
DOI 10.1053/euhj.1998.1188
-
Leyva F, Anker SD, Godsland IF, et al. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J 1998;19:1814-22 (Pubitemid 28556651)
-
(1998)
European Heart Journal
, vol.19
, Issue.12
, pp. 1814-1822
-
-
Leyva, F.1
Anker, S.D.2
Godsland, I.F.3
Teixeira, M.4
Hellewell, P.G.5
Kox, W.J.6
Poole-Wilson, P.A.7
Coats, A.J.S.8
-
55
-
-
12344285284
-
Uric acid in chronic heart failure
-
DOI 10.1016/j.semnephrol.2004.09.010, PII S0270929504001536, Uric Acid in Cardiovascular and Renal Disease
-
Doehner W, Anker SD. Uric acid in chronic heart failure. Semin Nephrol 2005;25:61-6 (Pubitemid 40128150)
-
(2005)
Seminars in Nephrology
, vol.25
, Issue.1
, pp. 61-66
-
-
Doehner, W.1
Anker, S.D.2
-
56
-
-
0021870226
-
Systemic response to local urate crystal induced inflammation in man: A possible model to study the acute phase response
-
Hutton CW, Collins AJ, Chambers RE, et al. Systemic response to local urate crystal induced inflammation in man: a possible model to study the acute phase response. Ann Rheum Dis 1985;44:533-6 (Pubitemid 15001293)
-
(1985)
Annals of the Rheumatic Diseases
, vol.44
, Issue.8
, pp. 533-536
-
-
Hutton, C.W.1
Collins, A.J.2
Chambers, R.E.3
-
57
-
-
77949658727
-
Association of serum uric acid with aortic stiffness and pressure in a Chinese workplace setting
-
Chen X, Li Y, Sheng CS, et al. Association of serum uric acid with aortic stiffness and pressure in a Chinese workplace setting. Am J Hypertens 2010;23:387-92
-
(2010)
Am J Hypertens
, vol.23
, pp. 387-392
-
-
Chen, X.1
Li, Y.2
Sheng, C.S.3
-
58
-
-
78650295009
-
Association of serum uric acid level with aortic stiffness and arterial wave reflections in newly diagnosed, never-treated hypertension
-
Vlachopoulos C, Xaplanteris P, Vyssoulis G, et al. Association of serum uric acid level with aortic stiffness and arterial wave reflections in newly diagnosed, never-treated hypertension. Am J Hypertens 2011;24:33-9
-
(2011)
Am J Hypertens
, vol.24
, pp. 33-39
-
-
Vlachopoulos, C.1
Xaplanteris, P.2
Vyssoulis, G.3
-
59
-
-
31944445992
-
Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension
-
DOI 10.1161/01.HYP.0000200033.14574.14
-
Iwashima Y, Horio T, Kamide K, et al. Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension 2006;47:195-202 (Pubitemid 43189763)
-
(2006)
Hypertension
, vol.47
, Issue.2
, pp. 195-202
-
-
Iwashima, Y.1
Horio, T.2
Kamide, K.3
Rakugi, H.4
Ogihara, T.5
Kawano, Y.6
-
60
-
-
20944452020
-
Serum uric acid and target organ damage in primary hypertension
-
DOI 10.1161/01.HYP.0000161184.10873.ea
-
Viazzi F, Parodi D, Leoncini G, et al. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005;45:991-6 (Pubitemid 40628949)
-
(2005)
Hypertension
, vol.45
, Issue.5
, pp. 991-996
-
-
Viazzi, F.1
Parodi, D.2
Leoncini, G.3
Parodi, A.4
Falqui, V.5
Ratto, E.6
Vettoretti, S.7
Bezante, G.P.8
Del Sette, M.9
Deferrari, G.10
Pontremoli, R.11
-
61
-
-
34248643147
-
Lack of Association Between Serum Uric Acid and Organ Damage in a Never-Treated Essential Hypertensive Population at Low Prevalence of Hyperuricemia
-
DOI 10.1016/j.amjhyper.2007.01.013, PII S0895706107000623
-
Cuspidi C, Valerio C, Sala C, et al. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Am J Hypertens 2007;20:678-85 (Pubitemid 46777264)
-
(2007)
American Journal of Hypertension
, vol.20
, Issue.6
, pp. 678-685
-
-
Cuspidi, C.1
Valerio, C.2
Sala, C.3
Meani, S.4
Esposito, A.5
Zanchetti, A.6
Mancia, G.7
-
62
-
-
0030479796
-
Identification of uric acid-in aortic aneurysms and atherosclerotic artery
-
DOI 10.1111/j.1749-6632.1996.tb33318.x
-
Patetsios P, Rodino W, Wisselink W, et al. Identification of uric acid in aortic aneurysms and atherosclerotic artery. Ann N Y Acad Sci 1996;800:243-5 (Pubitemid 27028964)
-
(1996)
Annals of the New York Academy of Sciences
, vol.800
, pp. 243-245
-
-
Patetsios, P.1
Rodino, W.2
Wisselink, W.3
Bryan, D.4
Kirwin, J.D.5
Panetta, T.F.6
-
63
-
-
0036224781
-
Xanthine oxidase is involved in free radical production in type 1 diabetes: Protection by allopurinol
-
Desco MC, Asensi M, Marquez R, et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 2002;51:1118-24 (Pubitemid 34438358)
-
(2002)
Diabetes
, vol.51
, Issue.4
, pp. 1118-1124
-
-
Desco, M.-C.1
Asensi, M.2
Marquez, R.3
Martinez-Valls, J.4
Vento, M.5
Pallardo, F.V.6
Sastre, J.7
Vina, J.8
-
64
-
-
1642484244
-
Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications
-
DOI 10.1113/jphysiol.2003.055913
-
Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol (Lond) 2004;555:589-606 (Pubitemid 38404582)
-
(2004)
Journal of Physiology
, vol.555
, Issue.3
, pp. 589-606
-
-
Berry, C.E.1
Hare, J.M.2
-
65
-
-
84861502810
-
Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease
-
Yelken B, Caliskan Y, Gorgulu N, et al. Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol 2012;77:275-82
-
(2012)
Clin Nephrol
, vol.77
, pp. 275-282
-
-
Yelken, B.1
Caliskan, Y.2
Gorgulu, N.3
-
66
-
-
33845447368
-
High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid
-
DOI 10.1161/CIRCULATIONAHA.106.651117, PII 0000301720061205000014
-
George J, Carr E, Davies J, et al. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006;114:2508-16 (Pubitemid 44901524)
-
(2006)
Circulation
, vol.114
, Issue.23
, pp. 2508-2516
-
-
George, J.1
Carr, E.2
Davies, J.3
Belch, J.J.F.4
Struthers, A.5
-
67
-
-
0038579374
-
Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2
-
DOI 10.1161/01.HYP.0000072820.07472.3B
-
Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogenactivated protein kinase and cyclooxygenase-2. Hypertension 2003;41:1287-93 (Pubitemid 36706079)
-
(2003)
Hypertension
, vol.41
, Issue.6
, pp. 1287-1293
-
-
Kanellis, J.1
Watanabe, S.2
Li, J.H.3
Kang, D.H.4
Li, P.5
Nakagawa, T.6
Wamsley, A.7
Sheikh-Hamad, D.8
Lan, H.Y.9
Feng, L.10
Johnson, R.J.11
-
68
-
-
34547733397
-
Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress
-
DOI 10.1152/ajpcell.00600.2006
-
Sautin YY, Nakagawa T, Zharikov S, et al Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/ nitrosative stress. Am J Physiol Cell Physiol 2007;293:C584-96 (Pubitemid 47235197)
-
(2007)
American Journal of Physiology - Cell Physiology
, vol.293
, Issue.2
-
-
Sautin, Y.Y.1
Nakagawa, T.2
Zharikov, S.3
Johnson, R.J.4
-
69
-
-
79952745185
-
Xanthine-oxidase inhibitors and statins in chronic heart failure: Effects on vascular and functional parameters
-
Greig D, Alcaino H, Castro PF, et al. Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters. J Heart Lung Transplant 2011;30:408-13
-
(2011)
J Heart Lung Transplant
, vol.30
, pp. 408-413
-
-
Greig, D.1
Alcaino, H.2
Castro, P.F.3
-
70
-
-
79958132608
-
Uric acid as a cardiometabolic risk factor: To be or not to be
-
Kanbay M, Afsar B, Covic A. Uric acid as a cardiometabolic risk factor: to be or not to be. Contrib Nephrol 2011;171:62-7
-
(2011)
Contrib Nephrol
, vol.171
, pp. 62-67
-
-
Kanbay, M.1
Afsar, B.2
Covic, A.3
-
71
-
-
47049099695
-
The role of urate and xanthine oxidase inhibitors in cardiovascular disease
-
DOI 10.1111/j.1527-3466.2007.00029.x
-
George J, Struthers AD. The role of urate and xanthine oxidase inhibitors in cardiovascular disease. Cardiovasc Therapeut 2008;26:59-64 (Pubitemid 351421775)
-
(2008)
Cardiovascular Therapeutics
, vol.26
, Issue.1
, pp. 59-64
-
-
George, J.1
Struthers, A.D.2
-
72
-
-
0035199068
-
Uric acid is closely linked to vascular nitric oxide activity: Evidence for mechanism of association with cardiovascular disease
-
DOI 10.1016/S0735-1097(01)01643-6, PII S0735109701016436
-
Maxwell AJ, Bruinsma KA. Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 2001;38:1850-8 (Pubitemid 33116554)
-
(2001)
Journal of the American College of Cardiology
, vol.38
, Issue.7
, pp. 1850-1858
-
-
Maxwell, A.J.1
Bruinsma, K.A.2
-
73
-
-
0037047070
-
Allopurinol improves endothelial dysfunction in chronic heart failure
-
DOI 10.1161/01.CIR.0000022140.61460.1D
-
Farquharson CAR, Hill A, Belch JJ, et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002;106:221-6 (Pubitemid 34761303)
-
(2002)
Circulation
, vol.106
, Issue.2
, pp. 221-226
-
-
Farquharson, C.A.J.1
Butler, R.2
Hill, A.3
Belch, J.J.F.4
Struthers, A.D.5
-
74
-
-
1442348765
-
Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers
-
DOI 10.1016/j.amjcard.2003.11.046, PII S000291490301676X
-
Guthikonda S, Woods K, Sinkey CA, et al. Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers. Am J Cardiol 2004;93:664-8 (Pubitemid 38293087)
-
(2004)
American Journal of Cardiology
, vol.93
, Issue.5
, pp. 664-668
-
-
Guthikonda, S.1
Woods, K.2
Sinkey, C.A.3
Haynes, W.G.4
-
75
-
-
0033520357
-
Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure
-
Ekelund UE, Harrison RW, Shokek O, et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing induced heart failure. Circ Res 1999;5:437-45 (Pubitemid 29409620)
-
(1999)
Circulation Research
, vol.85
, Issue.5
, pp. 437-445
-
-
Ekelund, U.E.G.1
Harrison, R.W.2
Shokek, O.3
Thakkar, R.N.4
Tunin, R.S.5
Senzaki, H.6
Kass, D.A.7
Marban, E.8
Hare, J.M.9
-
76
-
-
0037155054
-
Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart
-
DOI 10.1161/hh0302.104531
-
Saavedra WF, Paolocci N, St. John ME, et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res 2002;90:297-304 (Pubitemid 34633931)
-
(2002)
Circulation Research
, vol.90
, Issue.3
, pp. 297-304
-
-
Saavedra, W.F.1
Paolocci, N.2
St. John, M.E.3
Skaf, M.W.4
Stewart, G.C.5
Xie, J.-S.6
Harrison, R.W.7
Zeichner, J.8
Mudrick, D.9
Marban, E.10
Kass, D.A.11
Hare, J.M.12
-
77
-
-
23644437342
-
Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure
-
DOI 10.1016/j.yjmcc.2005.04.008, PII S0022282805001513
-
Amado LC, Saliaris AP, Raju SV, et al. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing induced heart failure. J Mol Cell Cardiol 2005;39:531-6 (Pubitemid 41133738)
-
(2005)
Journal of Molecular and Cellular Cardiology
, vol.39
, Issue.3
, pp. 531-536
-
-
Amado, L.C.1
Saliaris, A.P.2
Raju, S.V.Y.3
Lehrke, S.4
St. John, M.5
Xie, J.6
Stewart, G.7
Fitton, T.8
Minhas, K.M.9
Brawn, J.10
Hare, J.M.11
-
78
-
-
0037630728
-
Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
-
DOI 10.1016/S0002-9149(03)00543-5
-
Castro PF, Greig D, Perez O, et al. Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2003;92:215-18 (Pubitemid 36835976)
-
(2003)
American Journal of Cardiology
, vol.92
, Issue.2
, pp. 215-218
-
-
Castro, P.F.1
Greig, D.2
Perez, O.3
Moraga, F.4
Chiong, M.5
Diaz-Araya, G.6
Padilla, I.7
Nazzal, C.8
Jalil, J.E.9
Vukasovic, J.L.10
Moreno, M.11
Corbalan, R.12
Lavandero, S.13
-
79
-
-
0037465808
-
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: The Framingham Heart Study
-
DOI 10.1161/01.CIR.0000057810.48709.F6
-
Vasan RS, Sullivan LM, Roubenoff R, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003;107:1486-91 (Pubitemid 36378485)
-
(2003)
Circulation
, vol.107
, Issue.11
, pp. 1486-1491
-
-
Vasan, R.S.1
Sullivan, L.M.2
Roubenoff, R.3
Dinarello, C.A.4
Harris, T.5
Benjamin, E.J.6
Sawyer, D.B.7
Levy, D.8
Wilson, P.W.F.9
D'Agostino, R.B.10
-
80
-
-
33748116331
-
The Effect of Xanthine Oxidase Inhibition Upon Ejection Fraction in Heart Failure Patients: La Plata Study
-
DOI 10.1016/j.cardfail.2006.05.005, PII S1071916406002557
-
Cingolani HE, Plastino JA, Escudero EM, et al. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata study. J Card Fail 2006;12:491-8 (Pubitemid 44307706)
-
(2006)
Journal of Cardiac Failure
, vol.12
, Issue.7
, pp. 491-498
-
-
Cingolani, H.E.1
Plastino, J.A.2
Escudero, E.M.3
Mangal, B.4
Brown, J.5
Perez, N.G.6
-
81
-
-
44649122196
-
Impact of Oxypurinol in Patients With Symptomatic Heart Failure. Results of the OPT-CHF Study
-
DOI 10.1016/j.jacc.2008.01.068, PII S073510970801139X
-
Hare JM, Mangal B, Brown J, et al; OPT-CHF Investigators. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol 2008;51:2301-9 (Pubitemid 351783365)
-
(2008)
Journal of the American College of Cardiology
, vol.51
, Issue.24
, pp. 2301-2309
-
-
Hare, J.M.1
Mangal, B.2
Brown, J.3
Fisher Jr., C.4
Freudenberger, R.5
Colucci, W.S.6
Mann, D.L.7
Liu, P.8
Givertz, M.M.9
Schwarz, R.P.10
-
82
-
-
76549098607
-
Uric acid-lowering treatment with benzbromarone in patients with heart failure: A double-blind placebo-controlled crossover preliminary study
-
Ogino K, Kato M, Furuse Y, et al. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail 2010;3:73-81
-
(2010)
Circ Heart Fail
, vol.3
, pp. 73-81
-
-
Ogino, K.1
Kato, M.2
Furuse, Y.3
-
83
-
-
84861189813
-
Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition
-
Harzand A, Tamariz L, Hare JM. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition. Congest Heart Fail 2012;18:179-82
-
(2012)
Congest Heart Fail
, vol.18
, pp. 179-182
-
-
Harzand, A.1
Tamariz, L.2
Hare, J.M.3
-
84
-
-
0036180824
-
Effect of allopurinol on mortality and hospitalisations in chronic heart failure: A retrospective cohort study
-
Struthers AD, Donnan PT, Lindsay P, et al. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart 2002;87:229-34 (Pubitemid 34177675)
-
(2002)
Heart
, vol.87
, Issue.3
, pp. 229-234
-
-
Struthers, A.D.1
Donnan, P.T.2
Lindsay, P.3
McNaughton, D.4
Broomhall, J.5
MacDonald, T.M.6
-
86
-
-
80051616824
-
Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris
-
Rajendra NS, Ireland S, George J, et al. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. J Am Coll Cardiol 2011;58:820-8
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 820-828
-
-
Rajendra, N.S.1
Ireland, S.2
George, J.3
-
87
-
-
79960141065
-
Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease
-
Kao MP, Ang DS, Gandy SJ, et al. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol 2011;22:1382-9
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 1382-1389
-
-
Kao, M.P.1
Ang, D.S.2
Gandy, S.J.3
-
88
-
-
79957951218
-
Febuxostat inhibition of endothelialbound XO: Implications for targeting vascular ROS production
-
Malik UZ, Hundley NJ, Romero G, et al. Febuxostat inhibition of endothelialbound XO: implications for targeting vascular ROS production. Free Radic Biol Med 2011;51:179-84
-
(2011)
Free Radic Biol Med
, vol.51
, pp. 179-184
-
-
Malik, U.Z.1
Hundley, N.J.2
Romero, G.3
-
89
-
-
33749071170
-
Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy
-
DOI 10.1016/j.freeradbiomed.2006.07.010, PII S0891584906004588
-
Baldus S, Mullerleile K, Chumley P, et al. Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy. Free Radic Biol Med 2006;41:1282-8 (Pubitemid 44466324)
-
(2006)
Free Radical Biology and Medicine
, vol.41
, Issue.8
, pp. 1282-1288
-
-
Baldus, S.1
Mullerleile, K.2
Chumley, P.3
Steven, D.4
Rudolph, V.5
Lund, G.K.6
Staude, H.-J.7
Stork, A.8
Koster, R.9
Kahler, J.10
Weiss, C.11
Munzel, T.12
Meinertz, T.13
Freeman, B.A.14
Heitzer, T.15
-
90
-
-
58149328542
-
Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: A randomized, double-blind, placebo-controlled trial
-
Muir SW, Harrow C, Dawson J, et al. Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 2008;39:3303-7
-
(2008)
Stroke
, vol.39
, pp. 3303-3307
-
-
Muir, S.W.1
Harrow, C.2
Dawson, J.3
-
91
-
-
84863479133
-
Xanthine oxidase inhibition for the treatment of cardiovascular disease: A systematic review and meta-analysis
-
Higgins P, Dawson J, Lees KR, et al. Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovasc Ther 2012;30:217-26
-
(2012)
Cardiovasc Ther
, vol.30
, pp. 217-226
-
-
Higgins, P.1
Dawson, J.2
Lees, K.R.3
|